Many have criticized the CORAL trial. One criticism is that "severe" renal lesions were not enrolled and were stented outside the trial because of patient or physician preference; likewise "mild" renal lesions were not enrolled and were sent to medical therapy. Therefore many lesions included in the trial were actually nonobstructive and of intermediate severity.
In this issue of the Journal, Murphy et al. (1) discuss data from high-risk subsets of the CORAL (Cardiovascular Outcomes in Renal Atherosclerotic Lesions) trial (2) , which included 947 patients with RAS randomized to stent placement plus medical therapy or to medical therapy alone. These patient subsets had high-grade stenoses at baseline, higher intra-arterial pressure gradients, and higher baseline blood pressure. The authors found no difference or significant treatment effect from stenting. We commend the authors for bringing this data to the public sphere.
Many have criticized the CORAL trial. One criticism is that "severe" renal lesions were not enrolled and were stented outside the trial because of patient or physician preference; likewise "mild" renal lesions were not enrolled and were sent to medical therapy. Therefore many lesions included in the trial were actually nonobstructive and of intermediate severity.
To the authors' credit, the CORAL trial has listed reasons for screening failures in the appendix showing that a higher degree of stenosis severity was not a reason for patient exclusion. However, critics respond that the "selection" happened before a patient was even considered for the study, an assertion that is hard to prove or disprove. Another criticism is Veryan. As for the question of hemodynamic benefit: If we assume that stenosis severity is the main driver of the effect of RAS on hypertension, then the method by which the stenosis is measured is important. The CORAL trial required a $60% stenosis, which the authors argue was a common threshold in use at that time and would therefore reflect general practice.
Anatomic stenosis is also variable, with angiographic stenosis often not matching actual stenosis. The majority of RAS is due to ostial stenosis, which is sometimes difficult to visualize in a standardized fashion on angiography. Pressure gradient assessment in the study required the on-site investigator's assessment of stenosis severity as $60% or <80%, and was considered "positive" if the gradient was $20 mm Hg. Even in those patients, however, this was not always strictly followed. other studies point to functional testing with dopamine as having an additional benefit and a greater area under the receiver-operating characteristic curve for these patients, and may therefore be the preferred test in questionable subsets (4-6). Renal fractional flow reserve is another potential functional study (7) that may be helpful. 
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